Retroviral vector sequences may interact with some internal promoters and influence expression
- PMID: 8788167
- DOI: 10.1089/hum.1996.7.2-159
Retroviral vector sequences may interact with some internal promoters and influence expression
Abstract
Although retroviral vectors show promise for gene therapy, their expression in animals has been low. An improved understanding of how promoters function from a retroviral vector should facilitate the design of improved vectors. In this study, liver-specific promoters were cloned into a retroviral vector and expression from the retroviral long terminal repeat (LTR) and the internal promoter was analyzed. In addition, oligomerized liver-specific transcription factor binding sites were placed upstream of each promoter in an attempt to increase expression further. Additional oligomerized binding sites only increased expression slightly or inhibited expression in hepatoma cells, suggesting that this is not an effective way to increase expression from a retroviral vector. Unexpectedly, the liver-specific albumin promoter was expressed at high levels from a retroviral vector in fibroblasts, suggesting that retroviral elements functioned as an enhancer. Furthermore, the addition of HNF-4 binding sites adjacent to the albumin promoter inhibited both the LTR and albumin promoter in fibroblasts, an effect that was probably mediated by inhibitory proteins present in nonhepatic cells that can bind to HNF-4 sites. These results suggest that both positive and negative influences can be transmitted between the LTR and the albumin promoter. In contrast, the liver-specific human alpha 1-antitrypsin promoter did not appear to interact with the LTR by either of these criteria. Retroviral vectors have sequences that may inhibit expression of the LTR and some internal promoters in vivo. We hypothesize that internal promoters that do not interact with the LTR in tissue culture will be resistant to inhibitory effects of retroviral sequences in vivo.
Similar articles
-
Liver-directed gene therapy: quantitative evaluation of promoter elements by using in vivo retroviral transduction.Proc Natl Acad Sci U S A. 1994 Feb 15;91(4):1460-4. doi: 10.1073/pnas.91.4.1460. Proc Natl Acad Sci U S A. 1994. PMID: 8108431 Free PMC article.
-
Construction of human factor IX expression vectors in retroviral vector frames optimized for muscle cells.Hum Gene Ther. 1996 Sep 10;7(14):1743-56. doi: 10.1089/hum.1996.7.14-1743. Hum Gene Ther. 1996. PMID: 8886845
-
Liver-directed gene therapy: a retroviral vector with a complete LTR and the ApoE enhancer-alpha 1-antitrypsin promoter dramatically increases expression of human alpha 1-antitrypsin in vivo.Hum Gene Ther. 1996 Mar 20;7(5):637-45. doi: 10.1089/hum.1996.7.5-637. Hum Gene Ther. 1996. PMID: 8845389
-
Amplified and tissue-directed expression of retroviral vectors using ping-pong techniques.J Mol Med (Berl). 1995 Mar;73(3):113-20. doi: 10.1007/BF00198238. J Mol Med (Berl). 1995. PMID: 7633947 Review.
-
Cell type specific and inducible promoters for vectors in gene therapy as an approach for cell targeting.J Mol Med (Berl). 1996 Jul;74(7):379-92. doi: 10.1007/BF00210632. J Mol Med (Berl). 1996. PMID: 8841950 Review.
Cited by
-
Restricted transgene expression in the brain with cell-type specific neuronal promoters.Hum Gene Ther Methods. 2012 Aug;23(4):242-54. doi: 10.1089/hgtb.2012.073. Epub 2012 Aug 30. Hum Gene Ther Methods. 2012. PMID: 22934828 Free PMC article.
-
Loss of T cell-mediated antitumor immunity after construct-specific downregulation of retrovirally encoded T-cell receptor expression in vivo.Cancer Gene Ther. 2009 Feb;16(2):171-83. doi: 10.1038/cgt.2008.63. Epub 2008 Aug 8. Cancer Gene Ther. 2009. PMID: 18690205 Free PMC article.
-
Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery.J Virol. 1998 Dec;72(12):9873-80. doi: 10.1128/JVI.72.12.9873-9880.1998. J Virol. 1998. PMID: 9811723 Free PMC article.
-
Expression liver-directed genes by employing synthetic transcriptional control units.World J Gastroenterol. 2005 Sep 14;11(34):5295-302. doi: 10.3748/wjg.v11.i34.5295. World J Gastroenterol. 2005. PMID: 16149135 Free PMC article.
-
Identification of synthetic endothelial cell-specific promoters by use of a high-throughput screen.J Virol. 2004 Jun;78(12):6209-21. doi: 10.1128/JVI.78.12.6209-6221.2004. J Virol. 2004. PMID: 15163714 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
